Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 875

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 875
---
 incurred, as a result of Section 409A.

16. . Neither the Plan nor any Award will confer upon a Participant any right with respect to
continuing the Participant’s relationship as a Service Provider, nor will they interfere in any way with the Participant’s right or the right of the Company (or any Parent or Subsidiary of the Company) to terminate such relationship at any
time, with or without cause, to the extent permitted by Applicable Laws.

17. . The date of grant of an Award will be,
for all purposes, the date on which the Administrator makes the determination granting such Award, or such other later date as is determined by the Administrator. Notice of the determination will be provided to each Participant within a reasonable
time after the date of such grant.

18. . Subject to Section 23of the Plan, the Plan will become effective
upon the date (the “”) of the later of its approval by the Company’s stockholders and the consummation of the Aadi Merger. It will continue in effect until terminated earlier under Section 19of the
Plan, but no Incentive Stock Options may be granted after 10 years from the date the Plan is adopted by the Board.

19. .

(a) . The Administrator may at any time amend, alter, suspend or terminate
the Plan.

(b) . The Company will obtain stockholder approval of any Plan amendment to the extent necessary and
desirable to comply with Applicable Laws.

H-15

(c) . No amendment, alteration, suspension or
termination of the Plan will materially impair the rights of any Participant, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing and signed by the Participant and the Company.
Termination of the Plan will not affect the Administrator’s ability to exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination.

20. .

(a) . Shares will not be issued pursuant to an Award unless the exercise or vesting of such Award and the issuance and
delivery of such Shares will comply with Applicable Laws and will be further subject to the approval of counsel for the Company with respect to such compliance.

(b) . As a condition to the exercise or vesting of an Award, the Company may require the person exercising or
vesting in such Award to represent and warrant at the time of any such exercise or vesting that the Shares are being acquired only for investment and without any present intention to sell